Parkinson's disease, dopamine pathways, movement disorders, and neuroprotection
108 articles
Specific AQP4 genetic variants alter glymphatic drainage efficiency, directly influencing motor symptom severity and progression in early Parkinson's disease.
A major review reveals how the glymphatic system's failure drives neurodegeneration and brain tumor resistance — and how to fix it.
New mouse study reveals how the brain's waste-clearance system modulates toxic protein buildup linked to Parkinson's disease.
New research links age at Parkinson's onset and family history to the likelihood of carrying disease-causing genetic variants.
β-endorphin released during exercise wraps around toxic Aβ aggregates, forming a 'corona' that shields brain cells from Alzheimer's damage.
From Alzheimer's to Parkinson's, a wave of novel FDA approvals is expanding treatment options for serious neurological conditions.
A 79-year-old man developed involuntary movements weeks after carotid surgery, revealing a rare stroke complication.
A liver enzyme released during exercise may rejuvenate brain blood vessels and protect against cognitive decline and Alzheimer's pathology.
A comprehensive review examines how marine-derived bioactives like omega-3s, astaxanthin, and polysaccharides may combat chronic neuroinflammation underlying major neurodegenerative diseases.
Explore what actually happens inside your brain as you get older — from shrinking neuron networks to shifting brain chemicals — and discover why some people stay mentally sharp well into their 80s and beyond.
New review maps how α-synuclein assays may detect Parkinson's before symptoms appear — and what stands between lab and clinic.
A new Cell Metabolism study reveals how oxidative stress triggers astrocytes to produce collagen, forming barriers that kill neurons after stroke.
